Opening: Real Consultation Scenario
Clinic Note, March 2025, Beijing
A 41-year-old woman, AMH 0.9, FSH 11.6, with only 2 antral follicles in her left ovary. She came with a thick stack of reports and asked: "I've been researching for two months. Both Thailand and Kyrgyzstan offer IVF. Which one is truly more suitable for my condition? I don't mean which is cheaper—I really want to understand how to choose from a medical perspective." She had one previous failed IVF cycle, with 2 eggs retrieved at a local center, none forming a transferable blastocyst.
This question is not simply "which is better," but requires breaking down the match between policy, technology, laboratory conditions, and individual ovarian reserve.
Core Differences Between IVF in Thailand and Kyrgyzstan
Both Thailand and Kyrgyzstan offer IVF services to overseas patients, but their policy frameworks, technological levels, cost structures, and suitable patient profiles differ significantly. Direct answer:
- Thailand: Mature laboratory conditions, high prevalence of PGT (Preimplantation Genetic Testing) technology, doctors with extensive experience in complex cases (advanced age, recurrent failure, genetic issues). Policy does not allow third-party assisted reproduction (surrogacy) for non-residents, with strict restrictions on egg/sperm donation. Total cost approximately 120,000–160,000 RMB (including medical and living expenses).
- Kyrgyzstan: More liberal policy environment, significantly higher acceptance of third-party assisted reproduction, egg donation, and sperm donation. Laboratories and doctor experience are in a developmental phase; routine IVF cycles are manageable, but experience with complex genetic cases or very low ovarian reserve is relatively limited. Total cost approximately 80,000–110,000 RMB.
- Key Judgment: If you need PGT genetic screening, have very low ovarian reserve, or a history of multiple failed IVF cycles, Thailand's laboratory conditions and doctor experience are a better match. If you are price-sensitive, need third-party assisted reproduction or egg/sperm donation, and have relatively routine medical indications, Kyrgyzstan offers better value and policy flexibility.
Choosing Based on Reproductive Medicine Analysis
When doctors recommend a destination, they don't just look at success rates; they evaluate three levels:
- Ovarian Reserve and Embryo Potential: Patients with AMH below 1.0 and fewer than 5 antral follicles require higher laboratory standards for "blastocyst culture ability" and "embryo culture systems." Some Thai centers have more mature SOPs for continuous culture, low oxygen environments, and time-lapse monitoring, while Kyrgyzstan laboratories currently focus more on routine culture.
- Genetic Needs: For cases involving chromosomal translocations, single gene disorders, or recurrent miscarriage requiring PGT-A/PGT-M, Thailand offers more laboratory and genetic counseling options. PGT services in Kyrgyzstan are still under development with lower accessibility.
- Treatment Complexity: For older patients (≥40 years), those with low previous egg yield, or endometrial issues, Thai doctors have more experience in adjusting stimulation protocols and endometrial preparation. Kyrgyzstan doctors perform well with standard protocols but may have less flexibility in complex situations.
When Thailand is more suitable: Low ovarian reserve (AMH <1.0), need for PGT, history of failed IVF, recurrent implantation failure, advanced age (≥40), or clear genetic indications.
When Kyrgyzstan is more suitable: Need for third-party assisted reproduction, need for egg or sperm donation, limited budget, relatively routine medical indications (e.g., simple tubal factor, mild male factor), or specific requirements for policy flexibility.
Detailed Comparison of Assisted Reproduction Systems
The following details differences across policy, technology, cost, and process dimensions:
| Comparison Dimension | Thailand | Kyrgyzstan |
|---|---|---|
| Policy & Regulation | PGT (genetic screening) allowed; commercial surrogacy prohibited; egg/sperm donation strictly limited to legal donors | Liberal policy, high acceptance of third-party assisted reproduction, egg/sperm donation, relatively clear legal framework |
| Laboratory Standards | Multiple JCI-accredited or equivalent international labs; mature embryo culture, blastocyst formation rate, freezing/thawing technology | Laboratories in developmental phase; routine IVF culture competent; lower coverage of complex genetic testing and advanced culture techniques |
| Doctor Experience | Some doctors with overseas training; extensive experience with complex cases like advanced age, PCOS, recurrent failure | Smaller doctor teams; experience focused on routine cycles; complex case management experience still accumulating |
| Cost Range | Medical fees approx. 80,000–120,000 RMB; total cost (including accommodation, food, transport) approx. 120,000–160,000 RMB | Medical fees approx. 50,000–80,000 RMB; total cost approx. 80,000–110,000 RMB |
| Cycle Duration | Two visits to Thailand: stimulation + egg retrieval approx. 12–14 days, transfer approx. 5–7 days, total span approx. 25–30 days | Can be completed in one or two visits; stimulation + retrieval + transfer approx. 20–25 days; some centers offer compact scheduling |
| Language & Communication | Widespread Chinese language services; mature medical translation system | Primarily English; fewer Chinese services; need to arrange own translation or go through an agency |
| Transport & Visa | Many direct flights; visa on arrival/visa-free convenient | Limited direct flights (often require transit); e-visa process simple but needs advance application |
Most Easily Overlooked Details
Many people focus only on cost and success rates when comparing, but these details are often underestimated:
- Laboratory "Blastocyst Stability": For patients with poor ovarian reserve, whether embryos can develop to blastocysts is critical. Some Thai centers have specialized culture protocols for mini-stimulation cycles with ≤3 eggs, while some Kyrgyzstan centers may still use standard culture protocols. Recommended question: "What was the blastocyst formation rate for cycles with ≤3 eggs last year?"
- PGT Regulatory Applicability: Although Thailand allows PGT, regulations on embryo genetic testing have become more detailed since 2023, with some centers requiring genetic counseling records. Kyrgyzstan currently has fewer restrictions on PGT, but limited laboratories offering it.
- Medication Supply Chain: Imported stimulation drugs (Gonal-f, Puregon, etc.) are consistently available in Thailand with multiple brand options. Some medications in Kyrgyzstan need advance ordering, and waiting periods may affect cycle start timing.
- Follow-up and Monitoring Costs: If additional tests or medication adjustments are needed after transfer in Thailand, private hospitals in Bangkok can handle it quickly. In Kyrgyzstan, if complications or special tests arise, local medical resources may not be as accessible as in Bangkok.
Most Common Pitfalls
Based on observations from practitioners over the past few years, these issues recur:
- Attracted by "low all-inclusive" prices, ignoring hidden costs: Some Kyrgyzstan agencies quote 50,000–60,000 RMB for medical packages, but fine print may exclude PGT, multiple transfers, or specific medications. Actual final cost may approach 80,000–90,000 RMB. Similar situations exist in Thailand, but overall price transparency is higher.
- Underestimating the complexity and legal risks of third-party assisted reproduction: Despite Kyrgyzstan's liberal policy, practical steps involving legal agreements with donors/surrogates, nationality determination, and birth certificate processing each require independent legal review. It's not simply "arrive and do it."
- Over-reliance on success stories: Some patients try to replicate a friend's successful Thailand protocol directly, but everyone's ovarian reserve, cause of infertility, and physical condition are different. Thai doctors adjust protocols based on your AMH, FSH, and history, not templates. The same applies in Kyrgyzstan.
- Ignoring "what if the first cycle fails": In Thailand, most centers can offer consecutive cycle plans, with doctors retaining room for adjustment. In Kyrgyzstan, if the first cycle yields unsatisfactory egg numbers, options for changing protocols or referral are relatively limited.
Comparison of Actual IVF Processes
Thailand IVF Process (PGT Cycle Example)
- Preparation Phase (Home Country): Complete basic fertility assessment (AMH, FSH, LH, E2, antral follicle count), semen analysis, infectious disease screening, chromosome karyotype. Passport must be valid for at least 6 months. Registration requires notarized marriage certificate + translation. Recommended to complete tests 1–2 months in advance.
- First Visit to Thailand (Stimulation + Egg Retrieval): Start stimulation on day 2–3 of menstruation, average 10–12 days, with hormone and follicle monitoring. Egg retrieval surgery takes about 15–20 minutes under general anesthesia. Observation for 2–4 hours post-retrieval before discharge. Fertilization and embryo culture follow; blastocysts form after 5–6 days, biopsied and frozen.
- PGT Testing Waiting Period: Biopsy samples sent to genetics lab; results take approximately 14–21 days. Patient can return home while waiting.
- Second Visit to Thailand (Transfer): Based on endometrial preparation protocol (natural or hormone replacement cycle), transfer scheduled after ovulation or when lining is adequate. Blood test for hCG 10–12 days post-transfer.
Kyrgyzstan IVF Process (Routine Cycle)
- Preparation Phase: Similarly requires basic fertility assessment, semen analysis, infectious disease screening, chromosome testing. Same passport validity requirements. Some centers accept electronic test reports, but originals must be submitted before cycle start.
- Visit to Kyrgyzstan (Stimulation + Egg Retrieval + Transfer): Some centers offer a "one-stop" process: stimulation for 10–12 days, culture for 3–5 days after retrieval, and if endometrial conditions allow, proceed directly with fresh transfer. Total duration approximately 20–25 days. Frozen embryo transfer requires two visits.
- Third-Party Assisted Reproduction Process: If surrogacy or egg donation is involved, additional legal agreements are needed, matching with a surrogate or donor, extending the timeline to 2–4 months or more.
Suitable Candidate Analysis
Those more suited for Thailand:
- Low ovarian reserve (AMH <1.0) or advanced age (≥40), requiring high-standard embryo culture and blastocyst technology.
- Need for PGT-A or PGT-M genetic screening, especially for chromosomal structural abnormalities or single gene disorders.
- History of failed IVF cycles, requiring fine-tuned protocol adjustments based on previous cycle data.
- Clear requirements for laboratory accreditation and doctor experience, willing to pay higher costs.
Those more suited for Kyrgyzstan:
- Need for third-party assisted reproduction (surrogacy) or egg/sperm donation, with a desire for clear policy and legal compliance.
- Limited budget and relatively routine medical indications (e.g., simple tubal blockage, mild oligoasthenospermia).
- Cannot accept certain restrictions on embryo genetic testing in Thailand, or prefer a more flexible embryo handling environment.
- Require shorter travel distance and total stay time, hoping to complete stimulation + transfer in one visit (fresh transfer).
When blind choice is not advisable:
- AMH below 0.4 and unwilling to consider egg donation: Whether going to Thailand or Kyrgyzstan, the probability of obtaining a transferable embryo from own eggs drops significantly. Psychological and medical preparation is needed, not just changing destinations.
- Confirmed uterine abnormalities or severe intrauterine issues: Hysteroscopic evaluation should be done first domestically or locally, not directly starting a cycle.
- Chromosomal abnormalities without genetic counseling: If one partner has a balanced or Robertsonian translocation, a PGT protocol must be clarified under genetic counseling guidance before selecting a corresponding laboratory.
Risk Reminder
Any overseas assisted reproduction involves medical risks, legal differences, and financial uncertainty. The medical systems, regulatory intensity, and patient rights protection mechanisms differ between Thailand and Kyrgyzstan. Before making a decision, it is recommended to complete the following three steps:
- Obtain a complete evaluation report from a reproductive doctor, clarifying medical indications and required technology type.
- Conduct independent verification of medical institutions in the destination, including laboratory accreditation, doctor licenses, recent cycle numbers, and live birth rates (note: not "success rate" promises).
- Consult professional legal experts to understand destination laws regarding embryos, parentage determination, and birth certificates, especially when third-party assisted reproduction is involved.
Next Step Recommendations
If currently torn between the two destinations, first complete two sets of tests: ① Hormone panel + AMH + antral follicle count; ② Semen analysis + sperm DNA fragmentation; ③ Chromosome karyotype + genetic counseling. Take these reports for a remote pre-consultation with doctors at respective centers, asking clearly: "Given my current condition, what is your specific plan, expected outcome, and backup plan?" This step is more important than any agency introduction.
When to do overseas IVF tests How far in advance to prepare for overseas IVF Passport validity requirements for overseas IVF IVF male examination items IVF female examination items Can I do overseas IVF with low AMH What to prepare for advanced age overseas IVF How to prepare documents for overseas IVF Do I need to prepare my body before IVF Thailand IVF cost Kyrgyzstan IVF cost PGT genetic screening Third-party assisted reproduction Egg donation IVF Embryo culture Blastocyst formation rate